CO-DIAGNOSTICS, INC. ANNOUNCES THIRD QUARTER 2022 EARNINGS RELEASE DATE AND WEBCAST
Co-Diagnostics, Inc. (Nasdaq: CODX) will announce its third quarter 2022 results on November 10, 2022, after market close. The company will also host a conference call and webcast at 4:30 p.m. EDT to discuss financial outcomes with analysts and investors. Key management present will include CEO Dwight Egan, CFO Brian Brown, and Head of Investor Relations Andrew Benson. The event will be accessible via the company's website, with a recorded version available later for those unable to attend live.
- Scheduled third quarter 2022 earnings release for November 10, 2022.
- Management's conference call aims to enhance transparency with investors.
- None.
SALT LAKE CITY, Oct. 27, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its third quarter 2022 results on Thursday, November 10, 2022, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. EDT to discuss its financial results with analysts and institutional investors. Management on the call will include Dwight Egan, Chief Executive Officer, Brian Brown, Chief Financial Officer, and Andrew Benson, Head of Investor Relations.
The call and webcast will be available via:
Webcast: | ir.codiagnostics.com on the Events & Webcasts page |
Conference Call: | 877-317-6789 (domestic) or 412-317-6789 (international) |
If you are unable to participate during the live webcast, the call will be recorded and later made available on the Company's website.
About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.
View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-announces-third-quarter-2022-earnings-release-date-and-webcast-301661000.html
SOURCE Co-Diagnostics
FAQ
When will Co-Diagnostics announce its third quarter 2022 earnings?
What time is the Co-Diagnostics conference call for Q3 2022 results?
Who will be speaking during the Co-Diagnostics earnings call?
How can I access the Co-Diagnostics earnings call?
